Kleb-Gap Project
Infections caused by antibiotic-resistant Klebsiella pneumoniae (e.g., pneumonia)
ResearchActive
Key Facts
Indication
Infections caused by antibiotic-resistant Klebsiella pneumoniae (e.g., pneumonia)
Phase
Research
Status
Active
Company
About ACD Pharma
ACD Pharma is a private Norwegian biotech firm at the forefront of bacteriophage therapeutics. It has successfully commercialized a product for aquaculture (Custus®YRS) and is translating its technological platform to address critical human health challenges, particularly antibiotic-resistant infections like Klebsiella pneumoniae. The company is strategically positioned with strong academic and clinical partnerships and is scaling manufacturing capabilities with a new facility in Lofoten, aiming to become a key player in the global fight against antimicrobial resistance.
View full company profile